aTyr Pharma Announces Positive Biomarker Data from Phase 2 Clinical Trial of ATYR1923 Demonstrating Anti-Inflammatory Effects in COVID-19 Patients with Severe Respiratory Complications

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement